-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.50238.54% Upside
Akebia Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. has been rated by research analysts at H.C. Wainwright, Needham in the past 90 days.